Income Statement

v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Total Net Revenue $ 1,803,424 $ 2,763,202
Total Cost of Sales 989,375 1,776,640
Gross Profit 814,049 986,562
Operating Expenses:    
Research and development 369,243 486,626
Selling, general and administrative 1,070,610 1,323,049
Depreciation and amortization 14,795 16,931
Total Operating Expenses 1,454,648 1,826,606
Operating Loss (640,599) (840,044)
Other Expenses:    
Interest expense, net (8,680) (5,560)
Total Other Expenses (8,680) (5,560)
Loss before Provision for Income Taxes (649,279) (845,604)
Income Taxes Provision 3,222 0
Net Loss Attributable to Common Stockholders $ (652,501) $ (845,604)
Net Loss per Common Share:    
Basic - Net Loss Attributable to Common Stockholders $ (0.01) $ (0.01)
Diluted - Net Loss Attributable to Common Stockholders $ (0.01) $ (0.01)
Weighted Average Common Shares Outstanding used in Computing Basic Net Loss Per Share 135,990,491 134,793,211
Weighted Average Common Shares Outstanding used in Computing Diluted Net Loss Per Share 135,990,491 134,793,211
Product [Member]    
Total Net Revenue $ 1,609,262 $ 2,586,669
Total Cost of Sales 966,603 1,690,598
Recurring [Member]    
Total Net Revenue 194,162 176,533
Total Cost of Sales $ 22,772 $ 86,042

Source